International audienceThe modalities of mobilization of hematopoietic stem cells in autologous transplantation have evolved in recent years. The Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) organized the 9th hematopoietic stem cell transplantation clinical practices harmonization workshop series in September 2018 in Lille, France, to conduct a review of current practices of the society centers and of international recommendations. The cell dose objectives have been revised. The modalities of mobilization including the use of plerixafor have been specified allowing reaching the objectives of collection while limiting the number of apheresis. Collections failures have become exceptional.Les modalités de mo...
AbstractAutologous hematopoietic stem cell transplantation (aHSCT) is a well-established treatment f...
Autologous haematopoietic SCT with PBSCs is regularly used to restore BM function in patients with m...
As more efficient agents for stem cell mobilization are being developed, there is an urgent need to ...
International audienceThe modalities of mobilization of hematopoietic stem cells in autologous trans...
International audienceThe Francophone Society of Bone Marrow Transplantation and Cellular Therapy (S...
International audienceThe development of haplo-identical transplants brings to an increased resort t...
We retrospectively analyzed a total of 188 autologous stem cell transplantations (ASCT) performed in...
International audienceAutologous hematopoietic cell transplantation (AHCT) is a new treatment option...
International audienceIn September 2016 in Lille, France, the Francophone Society of Bone Marrow Tra...
National audienceTransferring a patient undergoing an allogeneic stem cell transplantation to the in...
International audienceThe Francophone Society of Bone Marrow Transplantation and Cellular Therapy (S...
International audienceSince, several years the integration of a clinical pharmacist in medical units...
The Francophone Society of Bone Morrow Transplantation and Cellular Therapy (SFGM-TC) organized the ...
Autologous haematopoietic SCT with PBSCs is regularly used to restore BM function in patients with m...
International audienceJACIE (Joint Accreditation Committee ISTC EBMT) regulations and standards impo...
AbstractAutologous hematopoietic stem cell transplantation (aHSCT) is a well-established treatment f...
Autologous haematopoietic SCT with PBSCs is regularly used to restore BM function in patients with m...
As more efficient agents for stem cell mobilization are being developed, there is an urgent need to ...
International audienceThe modalities of mobilization of hematopoietic stem cells in autologous trans...
International audienceThe Francophone Society of Bone Marrow Transplantation and Cellular Therapy (S...
International audienceThe development of haplo-identical transplants brings to an increased resort t...
We retrospectively analyzed a total of 188 autologous stem cell transplantations (ASCT) performed in...
International audienceAutologous hematopoietic cell transplantation (AHCT) is a new treatment option...
International audienceIn September 2016 in Lille, France, the Francophone Society of Bone Marrow Tra...
National audienceTransferring a patient undergoing an allogeneic stem cell transplantation to the in...
International audienceThe Francophone Society of Bone Marrow Transplantation and Cellular Therapy (S...
International audienceSince, several years the integration of a clinical pharmacist in medical units...
The Francophone Society of Bone Morrow Transplantation and Cellular Therapy (SFGM-TC) organized the ...
Autologous haematopoietic SCT with PBSCs is regularly used to restore BM function in patients with m...
International audienceJACIE (Joint Accreditation Committee ISTC EBMT) regulations and standards impo...
AbstractAutologous hematopoietic stem cell transplantation (aHSCT) is a well-established treatment f...
Autologous haematopoietic SCT with PBSCs is regularly used to restore BM function in patients with m...
As more efficient agents for stem cell mobilization are being developed, there is an urgent need to ...